Immunogenicity in a Phase 3 facilitated subcutaneous immunoglobulin study in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

被引：0
|
作者：
Hasan, Shabbir [1 ]
Wisseh, Steve [1 ]
Ay, Hakan [1 ]
Duff, Kim [1 ]
Nagy, Andras [2 ]
Chavan, Shailesh [3 ]
机构：
[1] Takeda Co, Shire US Inc, Cambridge, MA USA
[2] Takeda Co, Baxalta Innovat GmbH, Vienna, Austria
[3] Takeda Co, Shire US Inc, Lexington, MA USA
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2020年 / 25卷 / 04期
关键词：
Chronic inflammatory demyelinating polyradiculoneuropathy; facilitated subcutaneous immunoglobulin; immunogenicity;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
296
引用
收藏
页码：538 / 538
页数：1
相关论文
共 50 条
  • [41] Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
    Dziadkowiak, Edyta
    Waliszewska-Prosol, Marta
    Nowakowska-Kotas, Marta
    Budrewicz, Slawomir
    Koszewicz, Zofia
    Koszewicz, Magdalena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
  • [42] GLOBAL PHASE ILL EFFICACY, SAFETY, AND TOLERABILITY STUDY OF THE NOVEL SUBCUTANEOUS TREATMENT HYQVIA AND GAMMAGARD LIQUID/KIOVIG IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP)
    Yel, Leman
    Wisseh, Steve
    Duff, Kim
    Hasan, Shabbir
    Nagy, Andras
    MUSCLE & NERVE, 2019, 60 : S12 - S12
  • [43] GLOBAL PHASE III EFFICACY, SAFETY, AND TOLERABILITY STUDY OF THE NOVEL SUBCUTANEOUS TREATMENT HYQVIA AND GAMMAGARD LIQUID/ KIOVIG IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP)
    Glyman, Steve
    Wisseh, Steve
    Duff, Kim
    Hasan, Shabbir
    Nagy, Andras
    MUSCLE & NERVE, 2018, 58 : S49 - S49
  • [44] Clinical-neurophysiological correlations in chronic inflammatory demyelinating polyradiculoneuropathy patients treated with subcutaneous immunoglobulin
    Cirillo, Giovanni
    Todisco, Vincenzo
    Ricciardi, Dario
    Tedeschi, Gioacchino
    MUSCLE & NERVE, 2019, 60 (06) : 662 - 667
  • [45] Search for autoantibodies targeting the nodes of Ranvier in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
    Stathopoulos, P.
    Alexopoulos, H.
    Biba, A.
    Karagogeos, D.
    Dalakas, M. C.
    JOURNAL OF NEUROLOGY, 2014, 261 : S358 - S358
  • [46] Pulse intravenous methylprednisolone (IVMP) in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
    Machkhas, H
    Harati, Y
    NEUROLOGY, 1997, 48 (03) : 9002 - 9002
  • [47] PRESENCE OF REFLEXES MAY NOT EXCLUDE A DIAGNOSIS OF CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP)
    Rodrigues, Edrich
    Siejka, Tim
    Strathdee, James
    Kapoor, Mahima
    Zhang, Wen Wen
    Faragher, Mark
    Hutton, Elspeth
    Stark, Richard
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S119 - S119
  • [48] Misdiagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A two years follow-up study
    Pignolo, Antonia
    Di Stefano, Vincenzo
    Gagliardo, Andrea
    Lupica, Antonino
    Iacono, Salvatore
    Neto, Gabriele
    Brighina, Filippo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [49] A randomized controlled trial with Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
    Nobile-Orazio, Eduardo
    Cocito, Dario
    Lauria, Giuseppe
    Fazio, Raffaella
    Marchioni, Enrico
    Briani, Chiara
    Schenone, Angelo
    Santoro, Lucio
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 369 - 370
  • [50] CYTOTOXIC RESPONSE OF SERUM FROM PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP)
    ARMATI, PJ
    POLLARD, JD
    ACTA NEUROLOGICA SCANDINAVICA, 1987, 76 (01): : 24 - 27
12345